Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gazyva
Pharma
Roche's cancer med Gazyva scores FDA nod in lupus nephritis
With the lupus treatment landscape poised for a shake-up, Roche is hitting the scene with a new green light for its blood cancer drug Gazyva.
Fraiser Kansteiner
Oct 20, 2025 10:15am
Roche's Gazyva succeeds in key lupus nephritis trial
Feb 7, 2025 11:14am
Roche's Gazyva chases new kidney disease use with phase 3 win
Sep 26, 2024 11:30am
As Imbruvica fails, Brukinsa wins FDA nod in follicular lymphoma
Mar 7, 2024 4:08pm
FDA probes TG Therapeutics' Ukoniq for potential death risks
Feb 7, 2022 9:53am
Roche lands approval to slash Gazyvaro infusion time in EU
Oct 19, 2021 7:10am
